Foundations Investment Advisors LLC bought a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 5,000 shares of the company’s stock, valued at approximately $797,000.
A number of other hedge funds also recently modified their holdings of the stock. Squarepoint Ops LLC lifted its stake in shares of Direxion Daily S&P Biotech Bull 3x Shares by 33.2% during the 2nd quarter. Squarepoint Ops LLC now owns 161,146 shares of the company’s stock worth $9,171,000 after buying an additional 40,157 shares during the last quarter. Tower Research Capital LLC TRC raised its stake in Direxion Daily S&P Biotech Bull 3x Shares by 664.7% in the 3rd quarter. Tower Research Capital LLC TRC now owns 58,171 shares of the company’s stock worth $5,445,000 after purchasing an additional 50,564 shares in the last quarter. IMC Chicago LLC acquired a new stake in Direxion Daily S&P Biotech Bull 3x Shares in the 3rd quarter worth about $3,806,000. JPMorgan Chase & Co. acquired a new stake in Direxion Daily S&P Biotech Bull 3x Shares in the 3rd quarter worth about $3,208,000. Finally, Virtu Financial LLC acquired a new stake in Direxion Daily S&P Biotech Bull 3x Shares in the 3rd quarter worth about $1,757,000.
Direxion Daily S&P Biotech Bull 3x Shares Stock Performance
Shares of Direxion Daily S&P Biotech Bull 3x Shares stock opened at $195.30 on Monday. Direxion Daily S&P Biotech Bull 3x Shares has a twelve month low of $48.22 and a twelve month high of $212.45. The company has a 50-day simple moving average of $177.67 and a two-hundred day simple moving average of $167.85.
Direxion Daily S&P Biotech Bull 3x Shares Company Profile
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
Recommended Stories
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- These 3 CLO ETFs Target a Niche Corner of the Fixed-Income Market
- 3 Ways to Play the Data Center Land Grab
- The Smarter Way to Invest in AI Without Taking Extreme Risk
- 3 Dividend Kings That Earn Their Crown Every Quarter
Want to see what other hedge funds are holding LABU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Free Report).
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.
